| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.23 | 0.04 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.05 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |